NEW_buttonjapanese pharmaceutical company shionogi is about to start phase 3 of an antiviral against covid19 called s-217622 similar to pfizer's paxlovid that in phase 2b managed to reduce viral load: it would be great to have more therapeutic candidates folded_handslight_skin_tonefolded_handslight_skin_tonefolded_handslight_skin_tone via